Valuation (71%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.40 | N/A |
| PEG Ratio (TTM) | 0.12 | N/A |
| P/S Ratio (TTM) | 13.18 | N/A |
| P/B Ratio (TTM) | 0.89 | N/A |
| P/FCF Ratio (TTM) | 27.96 | N/A |
| Price to 5YR AVG Earnings Ratio | 75.57 | N/A |
| Price to 5YR AVG FCF Ratio | 15.54 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.07% | N/A |
| ROE (TTM) | 6.75% | N/A |
| Net Profit Margin (TTM) | 98.40% | N/A |
| ROIC 5YR AVG | 5.04% | N/A |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 112.50% | 46.25% | -562.77% |
| Revenue | 5.63% | 50.05% | -1,474.28% |
| Net Income | 112.13% | 46.50% | -561.53% |
| Cash Flow | -0.52% | 158.31% | 93.85% |
Health (58%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.12 | N/A |
| Quick Ratio (TTM) | 3.12 | N/A |
| D/E Ratio (TTM) | 0.00 | N/A |
| Interest Coverage (TTM) | 2.09 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.01 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | 0.07% | N/A |